Entasis Therapeutics to Present on ETX2514SUL at IDWeek 2018
03 oct. 2018 08h00 HE
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial...
Entasis Therapeutics Announces Pricing of Initial Public Offering
25 sept. 2018 21h55 HE
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...